Combinatorial Effect of DCA and Let-7a on Triple-Negative MDA-MB-231 Cells: A Metabolic Approach of Treatment

dc.contributor.authorSharma, P
dc.contributor.authorSingh, S.
dc.date.accessioned2020-07-16T07:41:58Z
dc.date.accessioned2024-08-14T07:40:38Z
dc.date.available2020-07-16T07:41:58Z
dc.date.available2024-08-14T07:40:38Z
dc.date.issued2020
dc.description.abstractDichloroacetate (DCA) is a metabolic modulator that inhibits pyruvate dehydrogenase activity and promotes the influx of pyruvate into the tricarboxylic acid cycle for complete oxidation of glucose. DCA stimulates oxidative phosphorylation (OXPHOS) more than glycolysis by altering the morphology of the mitochondria and supports mitochondrial apoptosis. As a consequence, DCA induces apoptosis in cancer cells and inhibits the proliferation of cancer cells. Recently, the role of miRNAs has been reported in regulating gene expression at the transcriptional level and also in reprogramming energy metabolism. In this article, we indicate that DCA treatment leads to the upregulation of let-7a expression, but DCA-induced cancer cell death is independent of let-7a. We observed that the combined effect of DCA and let-7a induces apoptosis, reduces reactive oxygen species generation and autophagy, and stimulates mitochondrial biogenesis. This was later accompanied by stimulation of OXPHOS in combined treatment and was thus involved in metabolic reprogramming of MDA-MB-231 cells. � 2020 Sage Publications.en_US
dc.identifier.doi10.1177/1534735420911437
dc.identifier.issn15347354
dc.identifier.urihttps://kr.cup.edu.in/handle/32116/2685
dc.identifier.urlhttps://journals.sagepub.com/doi/10.1177/1534735420911437
dc.language.isoenen_US
dc.publisherSAGE Publications Inc.en_US
dc.subjectbreast canceren_US
dc.subjectDCAen_US
dc.subjectmetabolic reprogrammingen_US
dc.subjectmiRNAen_US
dc.subjectmitogenesisen_US
dc.subjectOXPHOSen_US
dc.titleCombinatorial Effect of DCA and Let-7a on Triple-Negative MDA-MB-231 Cells: A Metabolic Approach of Treatmenten_US
dc.title.journalIntegrative Cancer Therapiesen_US
dc.typeArticleen_US
dc.type.accesstypeOpen Accessen_US

Files